Literature DB >> 2423814

The relationship between atrial granularity and circulating atrial natriuretic peptide in hamsters with congestive heart failure.

B S Edwards, D M Ackermann, T R Schwab, D M Heublein, W D Edwards, L E Wold, J C Burnett.   

Abstract

The BIO 14.6 strain of hamster is a model of familial cardiomyopathy complicated by congestive heart failure, sodium retention, and edema. In previous studies, bioassay techniques have demonstrated that the cardiac content of atrial natriuretic peptide (ANP) is reduced in these animals. On the basis of this observation, the syndrome of congestive heart failure has been hypothesized to be due to a deficiency in ANP. The current study was designed to correlate the cardiac content of ANP (determined by immunohistochemical techniques) with plasma circulating ANP (determined by radioimmunoassay). alpha-ANP antibodies were used for both determinations. The content of ANP in the atria was based on the degree of immunoreactive staining present (1 = lowest; 5 = highest), as graded by two observers. The mean granularity score of the cardiomyopathic hamsters was decreased (2.1 +/- 0.3) in comparison with that of age- and sex-matched control animals (3.5 +/- 0.5; P less than 0.05). In contrast, circulating immunoreactive ANP was higher in the hamsters with congestive heart failure than in the control animals--185.5 +/- 27.2 pg/ml versus 77.7 +/- 10.8 pg/ml (P less than 0.005). This study demonstrates that an inverse relationship exists between ANP content in the atria and circulating ANP. Furthermore, this study suggests that these hamsters with congestive heart failure are not deficient in ANP; rather, secretion of ANP is stimulated and storage of the peptide, represented by atrial granularity, is reduced.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423814     DOI: 10.1016/s0025-6196(12)61998-3

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  7 in total

1.  Morphological and morphometric study of atrial specific granules and other secretory components in dogs experimentally infected with Trypanosoma cruzi.

Authors:  M V Caliari; M Lana; V H Leite; W L Tafuri
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

2.  Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure.

Authors:  B S Edwards; D M Ackermann; M E Lee; G S Reeder; L E Wold; J C Burnett
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients.

Authors:  C J O'Neill; A Charlett; R J Dobbs; A A Deshmukh; S G Bowes; C Weller; P W Nicholson; J S Milledge; S M Dobbs
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

4.  ANF in experimental congestive heart failure.

Authors:  M Cantin; G Thibault; J F Ding; J Gutkowska; R Garcia; G Jasmin; P Hamet; J Genest
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

5.  Morphometric analysis of atrial natriuretic peptide-containing granules in atriocytes of rats with experimental congestive heart failure.

Authors:  N Avramovitch; A Hoffman; J Winaver; A Haramati; D Lewinson
Journal:  Cell Tissue Res       Date:  1995-03       Impact factor: 5.249

6.  Lung is an important source of atrial natriuretic factor in experimental cardiomyopathy.

Authors:  J Gutkowska; M Nemer; M J Sole; J Drouin; P Sirois
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 7.  Atrial natriuretic factor: physiologic actions and implications in congestive heart failure.

Authors:  B S Edwards; R S Zimmerman; J C Burnett
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.